comparemela.com

Latest Breaking News On - Amy jobe - Page 7 : comparemela.com

Cardiff Oncology to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a.

Mark erlanderAmy jobeVicki kelemenJoyce allaireCardiff oncology incMaxim groupLifesci communicationsCardiff oncologyGrowth conferenceOncology contact

Theseus Pharmaceuticals Announces Business Highlights and Reports Fourth Quarter and Full Year 2021 Financial Results

/PRNewswire/ Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the.

United kingdomUnited statesTim clacksonAmy jobeChristen baglaneasExchange commissionAmerican association for cancer researchLifesci communicationsTheseus pharmaceuticalsTheseus pharmaceuticals incChief executive officerBusiness highlightsAnticipated milestonesAmerican associationCancer researchAnnual meeting

Cardiff Oncology Announces Upcoming Poster Presentations at the AACR Annual Meeting

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a.

United statesNew orleansAmy jobeVicki kelemenJoyce allaireExchange commissionCardiff oncology incAmerican association for cancer researchLifesci communicationsErnestn morial convention centerCardiff oncologyAmerican associationCancer researchAnnual meetingConvention centerTherapeutic benefit

Cardiff Oncology to Participate in Cowen s 42nd Annual Healthcare Conference

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a.

Amy jobeVicki kelemenJoyce allaireCardiff oncology incLifesci communicationsPrnewswire cardiff oncology incGastrointestinal genitourinary oncology panelAnnual healthcare conferenceAnnual healthcareCardiff oncologyOncology contact

Cardiff Oncology to Participate in Cowen s 42nd Annual Healthcare Conference

/PRNewswire/ Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a.

Amy jobeVicki kelemenJoyce allaireCardiff oncology incLifesci communicationsPrnewswire cardiff oncology incGastrointestinal genitourinary oncology panelAnnual healthcare conferenceAnnual healthcareCardiff oncologyOncology contactHealth care amp hospitalsMedical pharmaceuticalsTrade show news

vimarsana © 2020. All Rights Reserved.